UroLift System by Teleflex Interventional Urology

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It is indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45* years or older (*50 years outside U.S.) and is the only BPH procedure that does not require cutting, heating or removal of prostate tissue. 

Join our team of innovative, talented people who are on a mission to empower healthcare providers with BPH solutions that have the potential to improve the health and quality of life for millions of men, every year.   

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. For more information, visit Teleflex.com. 

** Management estimate based on product sales and average units per procedure. For patient safety information, visit https://www.urolift.com/patient-safety.

Sign up for free to view info

Email Format Employee directory